A randomized, controlled, blinded human trial of GHK-Cu monotherapy, with a vehicle-only control (and a needling-plus-vehicle arm if a procedure is used), objective endpoints such as blinded global photography and target-area hair counts over at least several months, adequate statistical power, pre-registration, and independent replication
Most studies focus on GH replacement therapy rather than GHRP-mediated GH stimulation
It's when your body can't make intrinsic factor, the protein needed to absorb B12
This multi-pathway approach may explain its effectiveness for chronic conditions that fail to respond to treatments targeting only one aspect of the healing process
Disclaimer: This product is not designed to diagnose, treat, cure or prevent any condition
doi:10.1002/jbm.b.30246